D-chiro-inositol

N/A

Report date: 2022/07/19 16:22:54
NME

Base Information

Drug NameD-chiro-inositol
Drug Alias NameINS-1DCI
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizers
TargetsNot applicable
Therapy Area/IndicationsDiabetes Mellitus, Type 1Polycystic Ovary Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesItaly
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesInsmed
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Active IndicationsN/A
Inactive IndicationsDiabetes Mellitus, Type 1Polycystic Ovary Syndrome

Other Information

ATC CodeN/A
Related LinksN/A